These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 17292332

  • 1. Muc4 is required for activation of ErbB2 in signet ring carcinoma cell lines.
    Yokoyama A, Shi BH, Kawai T, Konishi H, Andoh R, Tachikawa H, Ihara S, Fukui Y.
    Biochem Biophys Res Commun; 2007 Mar 30; 355(1):200-3. PubMed ID: 17292332
    [Abstract] [Full Text] [Related]

  • 2. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways.
    Jepson S, Komatsu M, Haq B, Arango ME, Huang D, Carraway CA, Carraway KL.
    Oncogene; 2002 Oct 24; 21(49):7524-32. PubMed ID: 12386815
    [Abstract] [Full Text] [Related]

  • 3. MUC4 involvement in ErbB2/ErbB3 phosphorylation and signaling in response to airway cell mechanical injury.
    Theodoropoulos G, Carraway CA, Carraway KL.
    J Cell Biochem; 2009 May 01; 107(1):112-22. PubMed ID: 19288496
    [Abstract] [Full Text] [Related]

  • 4. MUC4 interacts with ErbB2 in human gallbladder carcinoma: potential pathobiological implications.
    Miyahara N, Shoda J, Ishige K, Kawamoto T, Ueda T, Taki R, Ohkohchi N, Hyodo I, Thomas MB, Krishnamurthy S, Carraway KL, Irimura T.
    Eur J Cancer; 2008 May 01; 44(7):1048-56. PubMed ID: 18397823
    [Abstract] [Full Text] [Related]

  • 5. MUC4 expression and its relation to ErbB2 expression, apoptosis, proliferation, differentiation, and tumor stage in non-small cell lung cancer (NSCLC).
    Karg A, Dinç ZA, Başok O, Uçvet A.
    Pathol Res Pract; 2006 May 01; 202(8):577-83. PubMed ID: 16814944
    [Abstract] [Full Text] [Related]

  • 6. Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas.
    Kobayashi M, Iwamatsu A, Shinohara-Kanda A, Ihara S, Fukui Y.
    Oncogene; 2003 Mar 06; 22(9):1294-301. PubMed ID: 12618754
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms behind signet ring cell carcinoma formation.
    Fukui Y.
    Biochem Biophys Res Commun; 2014 Aug 08; 450(4):1231-3. PubMed ID: 25019985
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
    Maegawa M, Takeuchi K, Funakoshi E, Kawasaki K, Nishio K, Shimizu N, Ito F.
    Mol Cancer Res; 2007 Apr 08; 5(4):393-401. PubMed ID: 17426253
    [Abstract] [Full Text] [Related]

  • 11. MUC4 and ErbB2 expression in squamous cell carcinoma of the upper aerodigestive tract: correlation with clinical outcomes.
    Weed DT, Gomez-Fernandez C, Yasin M, Hamilton-Nelson K, Rodriguez M, Zhang J, Carraway KL.
    Laryngoscope; 2004 Aug 08; 114(8 Pt 2 Suppl 101):1-32. PubMed ID: 15284539
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Production and localization of Muc4/sialomucin complex and its receptor tyrosine kinase ErbB2 in the rat lacrimal gland.
    Arango ME, Li P, Komatsu M, Montes C, Carraway CA, Carraway KL.
    Invest Ophthalmol Vis Sci; 2001 Nov 08; 42(12):2749-56. PubMed ID: 11687512
    [Abstract] [Full Text] [Related]

  • 14. ErbB3 expression predicts tumor cell radiosensitization induced by Hsp90 inhibition.
    Dote H, Cerna D, Burgan WE, Camphausen K, Tofilon PJ.
    Cancer Res; 2005 Aug 01; 65(15):6967-75. PubMed ID: 16061682
    [Abstract] [Full Text] [Related]

  • 15. Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor.
    Komatsu M, Jepson S, Arango ME, Carothers Carraway CA, Carraway KL.
    Oncogene; 2001 Jan 25; 20(4):461-70. PubMed ID: 11313977
    [Abstract] [Full Text] [Related]

  • 16. MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma.
    Tsutsumida H, Goto M, Kitajima S, Kubota I, Hirotsu Y, Wakimoto J, Batra SK, Imai K, Yonezawa S.
    Lung Cancer; 2007 Feb 25; 55(2):195-203. PubMed ID: 17126950
    [Abstract] [Full Text] [Related]

  • 17. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
    Chaturvedi P, Singh AP, Moniaux N, Senapati S, Chakraborty S, Meza JL, Batra SK.
    Mol Cancer Res; 2007 Apr 25; 5(4):309-20. PubMed ID: 17406026
    [Abstract] [Full Text] [Related]

  • 18. Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line.
    Nagy P, Friedländer E, Tanner M, Kapanen AI, Carraway KL, Isola J, Jovin TM.
    Cancer Res; 2005 Jan 15; 65(2):473-82. PubMed ID: 15695389
    [Abstract] [Full Text] [Related]

  • 19. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
    Pedersen NM, Breen K, Rødland MS, Haslekås C, Stang E, Madshus IH.
    Mol Cancer Res; 2009 Feb 15; 7(2):275-84. PubMed ID: 19208749
    [Abstract] [Full Text] [Related]

  • 20. Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer.
    Senapati S, Chaturvedi P, Sharma P, Venkatraman G, Meza JL, El-Rifai W, Roy HK, Batra SK.
    Br J Cancer; 2008 Sep 16; 99(6):949-56. PubMed ID: 18781152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.